ArticleDrug design, development and therapy2020

HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial-Mesenchymal Transition.

Huachen Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.